Galectin Therapeutics logo

Galectin Therapeutics Share Price (NASDAQ: GALT)

$3.98

-0.12

(-2.93%)

Live

Last updated on

Check the interactive Galectin Therapeutics Stock chart to analyse performance

Galectin Therapeutics Inc Key Stats

Check Galectin Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.1
Open
$4.01
Market Capitalization
$262.6M
Today's Volume
$253.7K
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.64
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3727.95%

Stock Returns calculator for Galectin Therapeutics Stock including INR - Dollar returns

The Galectin Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Galectin Therapeutics investment value today

Current value as on today

₹1,68,121

Returns

₹68,121

(+68.12%)

Returns from Galectin Therapeutics Stock

₹63,786 (+63.79%)

Dollar Returns*

₹4,335 (+4.33%)

Indian investors sentiment towards Galectin Therapeutics Stock

-70%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Galectin Therapeutics Stock from India on INDmoney has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Galectin Therapeutics Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    3.41%

  • BlackRock Inc

    2.21%

  • Advisor Group Holdings, Inc.

    1.91%

  • Geode Capital Management, LLC

    1.33%

  • Geneos Wealth Management Inc

    1.33%

  • Sontag Advisory LLC

    0.75%

Analyst Recommendation on Galectin Therapeutics Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Galectin Therapeutics(by analysts ranked 0 to 5 stars)

Galectin Therapeutics Share Price Target

What analysts predicted

Upside of 50.75%

Target:

$6.00

Current:

$3.98

Galectin Therapeutics share price target is $6.00, a slight Upside of 50.75% compared to current price of $3.98 as per analysts' prediction.

Galectin Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, GALT stock has moved up by 40.9%

Galectin Therapeutics Technicals Summary

Sell

Neutral

Buy

Galectin Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Galectin Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Galectin Therapeutics Inc logo
33.99%
180.82%
68.72%
230.65%
230.65%
Regeneron Pharmaceuticals, Inc. logo
5.52%
-17.35%
-50.85%
-1.12%
-3.68%
Beone Medicines Ltd logo
6.51%
21.35%
57.45%
73.21%
25.84%
Vertex Pharmaceuticals Incorporated logo
-14.26%
-17.97%
-18.13%
40.27%
45.64%
Alnylam Pharmaceuticals, Inc. logo
39.9%
82.53%
68.83%
115.41%
241.51%

About Galectin Therapeutics Inc

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Organization
Galectin Therapeutics
Employees
15
CEO
Mr. Joel Lewis CPA
Industry
Health Technology

Key Management of Galectin Therapeutics Inc

NameTitle
Mr. Joel Lewis CPA
President, CEO & Director
Mr. Jack W. Callicutt CPA
CFO, Treasurer & Corporate Secretary
Dr. Khurram Jamil M.D.
Chief Medical Officer
Mr. Robert Tritt J.D.
General Counsel
Mr. Jeff Katstra
Head of CMC & Pharmaceutical Development
Ms. Beth Knowles
Executive Assistant & Officer Manager

Important FAQs about investing in GALT Stock from India :

What is Galectin Therapeutics share price today?

Galectin Therapeutics share price today is $3.98 as on . Galectin Therapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Galectin Therapeutics share?

Galectin Therapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Galectin Therapeutics stock price today i.e. is trending at $3.98, lower by 9.75% versus the 52 week high.

How to invest in Galectin Therapeutics Stock (GALT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Galectin Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Galectin Therapeutics Shares that will get you 0.3769 shares as per Galectin Therapeutics share price of $3.98 per share as on August 26, 2025 at 12:36 AM IST.

What is the minimum amount required to buy Galectin Therapeutics Stock (GALT) from India?

Indian investors can start investing in Galectin Therapeutics (GALT) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Galectin Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Galectin Therapeutics share’s latest price of $3.98 as on August 26, 2025 at 12:36 AM IST, you will get 2.5126 shares of Galectin Therapeutics. Learn more about fractional shares .

What are the returns that Galectin Therapeutics has given to Indian investors in the last 5 years?

Galectin Therapeutics stock has given 230.65% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?